QuidelOrtho Corporation Form 8-K Summary
Business Context and Reporting Period
QuidelOrtho Corporation furnished this Current Report on Form 8-K on July 7, 2022, following the May 27, 2022 completion of the business combination between Quidel Corporation and Ortho Clinical Diagnostics Holdings plc.
Financial Information and Key Metrics
The filing furnishes a presentation containing certain unaudited pro forma financial information based on the historical financial statements of Quidel and Ortho, with reclassification adjustments only. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus the Prior Comparable Period
The principal material event is the consummation of the Quidel-Ortho business combination. The filing does not present period-over-period operating results or a comparable-period analysis.
Guidance, Outlook, Risks, and Unusual Items
- The pro forma information does not include adjustments required under Regulation S-X Article 11 or ASC 805.
- The presentation is unaudited, subject to change, and may be amended or updated in a subsequent SEC filing or by other means.
- QuidelOrtho expected to file additional financial information with the SEC by August 15, 2022. That information could differ materially from the unaudited pro forma information in the presentation.
- The presentation was furnished under Regulation FD and is not deemed filed for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings.
Important Facts for Investors to Verify
- Review Exhibit 99.1 for the unaudited pro forma financial information and the specific reclassification adjustments.
- Verify the subsequent financial information filed by the company by the stated August 15, 2022 deadline.
- Assess the differences between the furnished presentation and the financial information subsequently filed under applicable SEC and accounting requirements.
- Confirm that the presentation remains available on QuidelOrtho’s investor-relations website, as the company may discontinue website availability.